|
|
Background We designed this trial to assess whether the addition of standardized Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse decreases postoperative stress urinary incontinence in women without preoperative symptoms of stress incontinence.
Methods Women who did not report symptoms of stress incontinence and who chose to undergo sacrocolpopexy to treat prolapse were randomly assigned to concomitant Burch colposuspension or to no Burch colposuspension (control) and were evaluated in a blinded fashion three months after the surgery. The primary outcomes included measures of stress incontinence (symptoms, stress testing, or treatment) and measures of urge symptoms. Enrollment was stopped after the first interim analysis because of a significantly lower frequency of stress incontinence in the group that underwent the Burch colposuspension.
Results Of 322 women who underwent randomization, 157 were assigned to Burch colposuspension and 165 to the control group. Three months after surgery, 23.8 percent of the women in the Burch group and 44.1 percent of the controls met one or more of the criteria for stress incontinence (P<0.001). There was no significant difference between the Burch group and the control group in the frequency of urge incontinence (32.7 percent vs. 38.4 percent, P=0.48). After surgery, women in the control group were more likely to report bothersome symptoms of stress incontinence than those in the Burch group who had stress incontinence (24.5 percent vs. 6.1 percent, P<0.001).
Conclusions In women without stress incontinence who are undergoing abdominal sacrocolpopexy for prolapse, Burch colposuspension significantly reduced postoperative symptoms of stress incontinence without increasing other lower urinary tract symptoms.
Source Information
From the Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, Ill. (L.B.); the Department of Obstetrics and Gynecology, Johns Hopkins University, Baltimore (G.W.C.); the Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston (P.F.); the Department of Obstetrics and Gynecology, University of Iowa, Iowa City (I.N.); the Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham (H.E.R.); the Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill (A.G.V.); the Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh (H.Z.); the Department of Biostatistics, University of Michigan, Ann Arbor (M.B.B.); and the Contraception and Reproductive Health Branch, Center for Population Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md. (A.M.W.).
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |
Previous
